Unterehmen auf Watchlist setzen
Elevance Health
ISIN: US0367521038
WKN: A12FMV
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Elevance Health · ISIN: US0367521038 · Business Wire (ID: 20241006390302)
07 Oktober 2024 02:00PM

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2024 Results on October 17, 2024


Elevance Health (NYSE: ELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

  • 888-947-9963 – Access Code - 3972058 (Domestic)
  • 312-470-0178 – Access Code - 3972058 (International)
  • 866-510-4837 – No Access Code (Domestic Replay)
  • 203-369-1943 – No Access Code (International Replay)

The replay will be available from 11:30 a.m. EDT on October 17, 2024, until the end of the day on November 16, 2024. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve over 113 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

Contact

Investor Relations:
Stephen Tanal
Investor.Relations@elevancehealth.com

Media Relations:
Leslie Porras
Leslie.Porras@elevancehealth.com

Visuelle Wertentwicklung / Kursverlauf · Elevance Health
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2024
BusinessWire
Kontakt:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422